NCT06522373 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06522373
Title	Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
Recruitment	Withdrawn
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	M.D. Anderson Cancer Center
Indications	T-cell acute lymphoblastic leukemia acute biphenotypic leukemia acute myeloid leukemia myelodysplastic syndrome
Therapies	TAK-169
Age Groups:	child \| adult \| senior
Covered Countries

Facility	Status	City	State	Zip	Country	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06522373Clinical Trial Detail